Fluidx Medical Technology is committed to developing innovative and easy to use medical devices.
The seasoned leadership team at Fluidx is comprised of successful entrepreneurs, well-known interventional physicians, and other proven industry leaders. The team is unified by a commitment to improving patient safety and care through the development of innovative, easy to use devices.
Who We Are
Libble Ginster, President & CEO
Libble has over 20 years of business & product leadership experience across life sciences and medtech. Most recently, she was the Global Business Leader for Vascular Technologies and Head of Strategy for Vascular Access Devices at Becton Dickinson (formerly C.R. Bard). Libble spent more than a decade at Becton Dickinson/C.R. Bard in leadership roles across marketing, strategy, and business development. In these roles, she managed M&A activities and corporate strategy, directed new product development initiatives, and led product commercialization efforts for several high growth platforms. Earlier in her career, Libble’s experience included marketing and strategy consulting at several early stage companies as well as leading global firms (Merck, Ernst & Young, PricewaterhouseCoopers). She started her career in investment banking with Lehman Brothers. She received her Master of Business Administration and Bachelor of Science in Engineering from Duke University.
Danny Smith, Director of Research & Development
Danny is a veteran R&D professional with over 20 years of experience in medical device design and development. Prior to joining Fluidx, he held R&D leadership positions at both established companies as well as in startup enterprises. In these roles, he led and advised teams through the product development process and launched numerous innovative medical devices across various platforms. His broad experience includes vascular devices, molecular diagnostic systems, and orthopedic products. He specializes in bringing device concepts to market, establishing quality management system processes, and directing team activities. He received his Master of Science in Mechanical Engineering and Bachelor of Science in Mechanical Engineering from Brigham Young University.
Christopher Phillips, Director of Regulatory & Clinical Affairs
Chris is a recognized leader with extensive experience in Medical Device Regulatory Affairs, Clinical Affairs, and Quality Assurance. Chris has brought innovative medical devices to market in the USA, Europe, and other global markets for large and small companies including Becton Dickinson, C.R. Bard, Boston Scientific, etc. Chris currently leads Fluidx Medical’s regulatory and clinical efforts, navigating the intersection of these two critical areas. Chris completed a Master of Science degree in Regulatory Affairs from the George Washington University and holds RAPS’ RAC (US) and ASQ’s CBA certifications.
Joshua Jones, Engineering & Polymer Science
Joshua brings many years of technical experience in materials science and polymer chemistry to Fluidx. He specializes in biomaterials, synthetic polymers, and polymer-based embolic agents. He received his Doctor of Philosophy (PhD) in Bioengineering and Biomedical Engineering from the University of Utah and his Bachelor of Science with Honors (BSH) in Chemistry from Berry College.
Jessica Karz, Engineering & Polymer Science
Jessica has over 5 years of experience in polymer science and chemical engineering. She focuses on polymer and embolic material development and production. She received her Bachelor of Science in Chemical Engineering from Montana State University.
Shawn Fojtik, Co-founder
Shawn is a successful medtech entrepreneur and serial innovator, founding numerous companies including Fluidx Medical, Control Medical, Distal Access, CIRCA Scientific, Pinyons (Covidien), Transit Scientific, Axiom (Teleflex), Occam, and PMT (Mallinckrodt). Earlier in his career, he held product development and commercial leadership roles with GE Medical, Boston Scientific, and Black and Decker. Shawn's clinical experience spans cardiovascular, peripheral vascular, electrophysiology, interventional oncology, vascular access, etc. He has over 75 issued or pending patents.
Lawrence Kronick, Co-founder
Lawrence has over 35 years of operational and commercial experience in cardiovascular, interventional radiology, electrophysiology, and imaging. Lawrence is the founder of Business Asia Consultants, Inc., a consulting company with associates in Miami, Sao Paulo, Tokyo, New Delhi, Hong Kong, and Beijing assisting medical device and equipment companies to expand and develop global sales distribution channels. He speaks both Mandarin and English.
Russell Stewart, PhD, Co-founder
Russell received his PhD in biochemistry from the University of California, Santa Barbara in 1989. After a postdoctoral fellowship at Harvard University, he worked at the Rowland Institute for Science in Cambridge, MA. In 1994, he joined the faculty of the Department of Bioengineering at the University of Utah. His long standing research interests are in biomimetic engineering. Russell is a Professor in Bioengineering, an Adjunct Professor in Biology, and an Adjunct Professor of Material Science and Engineering at the University of Utah.